These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 12958787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Local treatment of atopic dermatitis with calcineurin inhibitors].
    Langeland T.
    Tidsskr Nor Laegeforen; 2006 Jan 26; 126(3):321-2. PubMed ID: 16440040
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Topical calcineurin inhibitors revisited.
    Qureshi A, Fischer MA.
    Arch Dermatol; 2007 Apr 26; 143(4):545-6. PubMed ID: 17438195
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of topical calcineurin inhibitors in atopic dermatitis.
    Alomar A, Berth-Jones J, Bos JD, Giannetti A, Reitamo S, Ruzicka T, Stalder JF, Thestrup-Pedersen K, European Working Group on Atopic Dermatitis.
    Br J Dermatol; 2004 Dec 26; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
    [Abstract] [Full Text] [Related]

  • 9. Report of the Topical Calcineurin Inhibitor Task Force of the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma and Immunology.
    Fonacier L, Spergel J, Charlesworth EN, Weldon D, Beltrani V, Bernhisel-Broadbent J, Boguniewicz M, Leung DY, American College of Allergy, Asthma and Immunology, American Academy of Allergy, Asthma and Immunology.
    J Allergy Clin Immunol; 2005 Jun 26; 115(6):1249-53. PubMed ID: 15940142
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Topical calcineurin inhibitors in atopic eczema -- pro].
    Wollenberg A.
    Dtsch Med Wochenschr; 2006 Jul 14; 131(28-29):1614. PubMed ID: 16823713
    [No Abstract] [Full Text] [Related]

  • 12. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
    Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M.
    Ann Pharmacother; 2009 Dec 14; 43(12):1956-63. PubMed ID: 19903860
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of atopic eczema with calcineurin inhibitors].
    Luger TA, Bieber T, Meurer M, Mrowietz U, Schwarz T, Simon J, Werfel T, Zuberbier T.
    J Dtsch Dermatol Ges; 2005 May 14; 3(5):385-91. PubMed ID: 16372807
    [No Abstract] [Full Text] [Related]

  • 14. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
    Czarnecka-Operacz M, Jenerowicz D.
    J Dtsch Dermatol Ges; 2012 Mar 14; 10(3):167-72. PubMed ID: 21974750
    [Abstract] [Full Text] [Related]

  • 15. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
    Schneeweiss S, Doherty M, Zhu S, Funch D, Schlienger RG, Fernandez-Vidaurre C, Seeger JD.
    Dermatology; 2009 Mar 14; 219(1):7-21. PubMed ID: 19293564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
    Bieber T, Vick K, Fölster-Holst R, Belloni-Fortina A, Städtler G, Worm M, Arcangeli F.
    Allergy; 2007 Feb 14; 62(2):184-9. PubMed ID: 17298428
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.